Citation Impact
Citing Papers
Infection, inflammation, height, and longevity
2005 Standout
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
2007 Standout
Regulation of macrophage function in inflammation and atherosclerosis
2008
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Thiazolidinediones
2004 Standout
Inflammation and metabolic disorders
2006 StandoutNature
HDL-cholesterol and cardiovascular disease
2015
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
The metabolic syndrome
2010 Standout
Liver X receptors as integrators of metabolic and inflammatory signaling
2006
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
2003
Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide production
2005
The changing landscape of atherosclerosis
2021 StandoutNature
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
2011
Macrophage death and defective inflammation resolution in atherosclerosis
2009
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Future Therapeutic Directions in Reverse Cholesterol Transport
2010
Nonresolving Inflammation
2010 Standout
Direct antiatherosclerotic effects of PPAR agonists
2008
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins
2008
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Adipokines in inflammation and metabolic disease
2011 Standout
The metabolic syndrome
2005 Standout
Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis
2002
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
2012
The macrophage foam cell as a target for therapeutic intervention
2002
Fish Intake, Contaminants, and Human Health
2006 Standout
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
2002
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
RNAi-based therapeutic strategies for metabolic disease
2011
Dyslipidemia and inflammation: an evolutionary conserved mechanism
2005
Roles of peroxisome proliferator-activated receptor γ in lipid homeostasis and inflammatory responses of macrophages
2002
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Peroxisome Proliferator-Activated Receptors (PPARs) and Their Role in the Vessel Wall: Possible Mediators of Cardiovascular Risk?
2001
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Combinatorial roles of nuclear receptors in inflammation and immunity
2005
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?
2001
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Coordinate regulation of neutrophil homeostasis by liver X receptors in mice
2011
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
2003
Protective and pathogenic functions of macrophage subsets
2011 Standout
The Hallmarks of Aging
2013 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARγ mRNA expression and modulates SR-BI gene expression in murine macrophages
2005
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Aldosterone and end-organ damage
2005
C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones
2004
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
HDL as a target in the treatment of atherosclerotic cardiovascular disease
2005
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism
2003
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Diet, fatty acids, and regulation of genes important for heart disease
2004
Genetics of abdominal aortic aneurysm
2013
Inflammatory pathways in atherosclerosis and acute coronary syndromes
2001
Cellular senescence: from physiology to pathology
2014 Standout
Control of Macrophage Activation and Function by PPARs
2010
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation
2014
PPARγ and Atherosclerosis
2001
Markers of Inflammation and Cardiovascular Disease
2003 Standout
2001
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Osteopontin
2007
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
2003 Science
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease
2003
Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients Without Diabetes Mellitus
2004
Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons
2010
The Mechanisms of Action of PPARs
2002 Standout
Effect of Rosiglitazone Treatment on Plaque Inflammation and Collagen Content in Nondiabetic Patients
2006
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nuclear Receptors in Lipid Metabolism: Targeting the Heart of Dyslipidemia
2006
Macrophage Reverse Cholesterol Transport
2006
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis
2002
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
2005
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Lack of Association Between Adiponectin Levels and Atherosclerosis in Mice
2010
Liver X Receptor Signaling Pathways and Atherosclerosis
2010
Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells
2003
NUCLEAR RECEPTORS IN MACROPHAGE BIOLOGY: At the Crossroads of Lipid Metabolism and Inflammation
2004
Nanoparticles Containing a Liver X Receptor Agonist Inhibit Inflammation and Atherosclerosis
2014
Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes
2014 Nobel
Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes
2009
Vascular Calcification
2008 Standout
Insulin Resistance and Atherosclerosis
2006
Osteopontin at the Crossroads of Inflammation and Tumor Progression
2017
Endothelial Function and Dysfunction
2007 Standout
Works of Grace Noh being referenced
Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice
2003
Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice
2003
Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice
2001
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
2002